The Integrated Stress Response Links Muc5b to Pulmonary Fibrosis

Mariana M. Herrerias,G. R. Scott Budinger

DOI: https://doi.org/10.1165/rcmb.2022-0378ED

IF: 7.748

2022-12-31

American Journal of Respiratory Cell and Molecular Biology

Abstract:Pulmonary fibrosis is a chronic lung disease characterized by the destruction of the lung parenchyma and excessive deposition of the extracellular matrix, resulting in increased work of breathing, impaired gas exchange, and eventual death from respiratory failure. Although the molecular mechanisms underlying the development of pulmonary fibrosis are incompletely understood, a multicellular model of pulmonary fibrosis pathology is emerging. Genetic association studies in humans implicate failed repair of the alveolar epithelium as the initiating event in pulmonary fibrosis, acting upstream of the recruitment of profibrotic monocyte-derived alveolar macrophages from the circulation and activation of alveolar fibroblasts (1, 2). By far, the most common genetic factor associated with idiopathic pulmonary fibrosis is a mutation in the promoter region of a gene encoding MUC5B (epithelial mucin) (3). Mutations in other genes expressed only in the alveolar epithelium, for example, SFTPC (surfactant protein C), have also been associated with an increased risk of pulmonary fibrosis (4). Furthermore, investigators have used murine models to localize the profibrotic effects of mutations that reduce telomere length and cause the Hermansky-Pudlack syndrome to the alveolar epithelium (5, 6).

biochemistry & molecular biology,cell biology,respiratory system